DRREDDY Dr Reddy's Laboratories Ltd Expansion Plans Announcement 2024 - Licensing Agreement Dr. Reddys Laboratories has signed a voluntary licensing agreement with Gilead Sciences to manufacture and commercialize Lenacapavir for HIV treatment in India and 120 other countries, aiming to improve patient access in low- and middle-income regions..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Dr Reddy's Laboratories Ltd